Market Tracker

05/23 2:35pm ET

Nektar Therapeutics (NASDAQ:NKTR)

81.99
BATS BZX Real-Time Price
As of 2:32pm ET
 +0.04 / +0.05%
Today’s Change
17.51
Today|||52-Week Range
111.36
+37.29%
Year-to-Date

Today’s Trading

Previous close81.95
Today’s open81.50
Day’s range80.59 - 83.14
Volume60,646
Average volume (3 months)2,926,422
Market cap$13.9B
Data as of 2:32pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)+43.64%
Earnings growth (this year)+544.01%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+86.00%
P/E ratioNM
Price/Sales30.27
Price/Book147.00

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...+3.17+4.24%
----
XONIntrexon Corp+0.03+0.19%
BPMCBlueprint Medicines ...-1.70-2.02%
Data as of 2:35pm ET, 05/23/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$3.91
Annual revenue (last year)$307.7M
Annual profit (last year)-$96.7M
Net profit margin-31.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts